Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | AR | P10275 | 3/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 2/20 | 0.31 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.30 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14510530 | 0.84 | CES2 (0.38) | CES2CES1RIPK1 | |
| SCHEMBL1201613 | 0.81 | CES2 (0.39) | CES2CES1KIF11 | |
| SCHEMBL2608417 | 0.78 | CES2 (0.36) | CES2CES1RIPK1 | |
| SCHEMBL7829915 | 0.77 | MEN1 (0.32) | CES2CES1 | |
| SCHEMBL24901421 | 0.77 | MEN1 (0.39) | CES2CES1AR | |
| SCHEMBL11286517 | 0.77 | CES2 (0.37) | CES2CES1KIF11 | |
| SCHEMBL2974322 | 0.76 | CES2 (0.39) | CES2CES1KIF11 | |
| SCHEMBL30524326 | 0.75 | PDE2A (0.40) | CES2CES1KIF11 | |
| SCHEMBL8160495 | 0.75 | PDE2A (0.40) | CES2CES1KIF11 | |
| SCHEMBL29009844 | 0.75 | CES2 (0.41) | CES2CES1ARRIPK1KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1915331-B1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO KK (JP) | 2013-07-10 | — | — | EP | claimed |
| US-7939695-B2 | Production process of nucleus-halogenated methylbenzyl alcohol | SHOWA DENKO K.K. (JP) | 2011-05-10 | — | — | US | claimed |
| US-20100145106-A1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2010-06-10 | — | — | US | claimed |
| EP-1915331-A2 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | Showa Denko K.K. (JP) | 2008-04-30 | — | — | EP | claimed |
| WO-2006137348-A2 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2006-12-28 | — | — | WO | claimed |
| US-6828467-B2 | Industrial process of the hydrogenolysis of one hydroxyl or methanol group of a fluorinated benzenedimethanol carried out in a solvent in the presence of a catalyst; 2,3,5,6-tetra-fluorobenzyl alcohol from the 4-methyl derivative | SHOWA DENKO K.K. (JP) | 2004-12-07 | — | — | US | claimed |
| EP-1322584-B1 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | SHOWA DENKO KK (JP) | 2004-11-24 | — | — | EP | claimed |
| US-20040010167-A1 | Process for producing fluorinated methyl-benzyl alcohol | SHOWA DENKO K.K. (JP) | 2004-01-15 | — | — | US | claimed |
| EP-1322584-A2 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | Showa Denko K.K. (JP) | 2003-07-02 | — | — | EP | claimed |
| WO-2002026678-A2 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2002-04-04 | — | — | WO | claimed |
| EP-1915331-B1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO KK (JP) | 2013-07-10 | — | — | EP | disclosed |
| US-7939695-B2 | Production process of nucleus-halogenated methylbenzyl alcohol | SHOWA DENKO K.K. (JP) | 2011-05-10 | — | — | US | disclosed |
| US-20100145106-A1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2010-06-10 | — | — | US | disclosed |
| EP-1915331-A2 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | Showa Denko K.K. (JP) | 2008-04-30 | — | — | EP | disclosed |
| WO-2006137348-A2 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2006-12-28 | — | — | WO | disclosed |
| EP-1322584-B1 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | SHOWA DENKO KK (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-20040010167-A1 | Process for producing fluorinated methyl-benzyl alcohol | SHOWA DENKO K.K. (JP) | 2004-01-15 | — | — | US | disclosed |
| CN-1466560-A | Process for producing fluorinated methyl-benzyl alcohol | �Ѻ͵繤��ʽ���� | 2004-01-07 | — | — | CN | disclosed |
| EP-1322584-A2 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | Showa Denko K.K. (JP) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002026678-A2 | PROCESS FOR PRODUCING FLUORINATED METHYL-BENZYL ALCOHOL | SHOWA DENKO K.K. (JP) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010167-A1 | Process for producing fluorinated methyl-benzyl alcohol | ADH1C, ADH5, ADH1A | CES2 436/4885CES1 808/4885AR 2082/4885 |
| US-20100145106-A1 | PRODUCTION PROCESS OF NUCLEUS-HALOGENATED METHYLBENZYL ALCOHOL | NPM1, MED1, KPNA2 | CES2 1868/4885CES1 2776/4885AR 800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.